TRHC
Get informed when a big investor buys or sells
+ FollowUndervalued by 4.2% based on the discounted cash flow analysis.
| Market cap | $284.03 Million |
|---|---|
| Enterprise Value | $560.83 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.18 |
| Beta | 1.58 |
| Outstanding Shares | 25,422,032 |
| P/E Ratio | -3.3 |
|---|---|
| PEG | 14.74 |
| Price to Sales | 0.81 |
| Price to Book Ratio | -2.63 |
| Enterprise Value to Revenue | 1.66 |
| Enterprise Value to EBIT | -13.08 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.61 |
| Debt to Equity | -4.35 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
This committee's official revenue estimates and technical expertise directly influence tax legislation, including any specific excise taxes or corporate tax changes that significantly impact tobacco manufacturing profits and business models.
This committee's power over excise taxes on tobacco and international trade policies (tariffs, import/export) directly and significantly impacts the pricing, sales volume, and global market access for tobacco manufacturers.
The FDA's extensive regulatory power over tobacco products, including product standards, marketing restrictions, and ingredient regulation, makes this committee extremely influential for tobacco manufacturers.
This committee's jurisdiction over antitrust matters, intellectual property, and the Department of Justice makes it highly relevant for potential mergers, brand protection, and ongoing legal challenges faced by tobacco manufacturers.
The Federal Trade Commission (FTC), under this committee's oversight, directly regulates the advertising, marketing, and labeling practices of tobacco products, profoundly impacting the industry.